Loading organizations...
Loading organizations...
Biotechnology company developing therapeutics for brain cancer.
Divide and Conquer has raised $12.4M across 1 funding round.
Divide and Conquer has raised $12.4M in total across 1 funding round.
Divide and Conquer has raised $12.4M in total across 1 funding round.
Divide and Conquer's investors include David Grainger.
Divide and Conquer has raised $12.4M across 1 funding round. Most recently, it raised $12.4M Series A in September 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 18, 2019 | $12.4M Series A | David Grainger |